Oneness Biotech Co

Oneness Biotech Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Oneness Biotech Co (4743.TWO) as of Oct 30, 2026 is -3.52. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -1.23 — a change of 187.30% (lower).

PEG

-3.52

YoY

187.30%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Oneness Biotech Co is 2025 -3.52 . PEG Ratio (Price/Earnings-to-Growth) of Oneness Biotech Co was 2024 -1.23 . It decreases by 187.30% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oneness Biotech Co Stock analysis

What does Oneness Biotech Co do? Oneness Biotech Co., Ltd. generates revenue through the research and development of new drugs and the sale of pharmaceutical products and health products. The company focuses on health supplies, health food, and healthy food as its main products, which are distributed domestically. It also develops new drugs for treating chronic diabetic foot ulcers and anticancer drugs, targeting the domestic market for both its existing and new product lines. The firm's primary customers are domestic consumers seeking health and pharmaceutical solutions, including those requiring wound healing treatments for diabetic foot ulcers and anticancer therapies. Its product portfolio includes health supplies, health food, healthy food, and specialized drug developments, all sold within Taiwan's domestic market. Oneness Biotech's business model centers on developing and selling health and pharmaceutical products, with a particular emphasis on niche medical applications like diabetic foot ulcer treatments and cancer drugs. The company leverages its domestic distribution network to reach consumers interested in health-focused solutions and specialized medical treatments. Oneness Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oneness Biotech Co stock

PEG Ratio (Price/Earnings-to-Growth) of Oneness Biotech Co is -3.52 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Oneness Biotech Co changed from -1.23 to -3.52, representing a 187.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Oneness Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Oneness Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Oneness Biotech Co

All Key Metrics — Oneness Biotech Co